From Research to Practice:
Postgraduate Training Course in Reproductive Health/Chronic Disease
Geneva 2004

23 February – 2 April  2004

organised by

the Geneva Foundation for Medical Education and Research,
the International Association for Maternal and Neonatal Health (IAMANEH)
the UNDP/UNFPA/WHO/World Bank Special Programme for Research in Human Reproduction, Department of Reproductive Health and Research; Family and Community Health Cluster (WHO/RHR)
the WHO Noncommunicable Diseases and Mental Health Cluster (WHO/NMH)
and
Policy and Strategy on Traditional Medicine/Department of Essential Drugs and Medicines Policy and Department of Essential Health Technologies; Health Technology and Pharmaceuticals Cluster (WHO/HTP)

in collaboration with
the Department of Health of the Canton of Geneva
the Faculty of Medicine, Geneva University
and
the Geneva Medical Association

Opening ceremony - Images
Course files
List of lecturers
List of participants : Chronic disease
List of participants : Reproductive health
Dinner of March 24
Scientific reviews presented by the participants - Oral presentations

LECTURE PLAN

Common course: Research methodology at WHO/Salle B

The opening ceremony on 23 February will be held in the Executive Board Room, WHO

 Date AM Topic Speaker PM Topic Speaker
February 23 09.00 Organisational matters Organisers; venue: GFMER 13.00 Opening ceremony J Villar
C Tukuitonga
A Campana
PF Unger
J Philippe
B Bourrit
X Zhang
15.30 Welcome cocktail WHO/ Restaurant
February 24 09.00 The gap between evidence and practice in NCDs C Tukuitonga 14.00 Visit of the WHO library

 
10.15 The gap between evidence and practice in Reproductive Health J Villar
February 25 09.00 Types of epidemiological studies J Villar 14.00 Visit of the CMU library/computer rooms, Internet and Medline A Campana
10.15 Cohort studies H Wolff
11.15 Case-control studies H Wolff
February 26 09.00 Randomized controlled trials M Merialdi 14.00 Introduction to Excel, Word and Powerpoint S Koppenhoefer
10.15 Community interventions and equivalence trials G Piaggio 14.30 Computer basics S Koppenhoefer
February 27 09.00 Methodological issues in the measurement of maternal mortality and morbidity A Betran 14.00 Methodological issues in the measures of mental disorders M van Ommeren
10.15 Methodological issues in the measurement of chronic disease N Unwin
11.15 Methodological issues in the use of anthropometry for evaluation of nutritional status M Bloessner
March 01 09.00 Screening for obstetrics and intrapartum events M Merialdi      
10.15 Ethical issues in research E Vayena
March 02 09.00 Research synthesis, including meta-analysis M Gülmezoglu 14.00 How to write a scientific paper J Khanna
10.15 The Cochrane Collaboration R Kulier
11.15 Systematic reviews of observational data A Betran
March 03 09.00 - 10.30 Strategies for data analysis : cohort & case control studies I Malonza 14.00 Screening for chronic disorder K Strong
10.45 - 12.00
 		 Strategies for data analysis : RCT & community interventions G Piaggio
March 04 09.00 Introduction to health economics J Chen 14.00 Gender, Women's Health, Human Rights E Kismodi
10.15 Critical appraisal of research reports L Say
March 05 09.00 The WHO Reproductive Health Library A Shah      
10.15 Data analysis : summary J Villar

Course 1 : Reproductive Health at WHO/room M505

Lectures on March 10 will be held at the Faculty of Medicine (CMU), Geneva

 Date AM Topic Speaker PM Topic Speaker
March 08 09.00 Fertilisation/Implantation G Bianchi 14.00 From Reproductive Health to Contraception G Benagiano
10.00 The HPG axis R Gaillard
11.00 Puberty V Schwitzgebel
12.00 The menstrual cycle F Pralong
March 09 09.00 Polycystic ovary syndrome F Pralong  14.00 Diabetes and Reproduction J Philippe
10.00 Endometriosis D Chardonnens
11.00 Oral contraception and the HPG axis F Pralong
12.00 Estrogen (ER) receptor biology: Implications for HRT? C Meier
March 10 09.00 Introduction / Genetic consultation in OBGYN M Gersbach 14.00 Clinical pre - and postnatal cytogenetics S Gagos
10.00 Genetic counselling: principles, practice, ethics M Gersbach
11.00 Principles of molecular diagnosis M Morris 15.00 The human genome project, its implication for the practice of medicine in the 21st century S Antonarakis
March 11 09.00 Reproductive health research at WHO P v Look      
10.00 Long-acting hormonal contraceptive methods J Schmidt
11.00 Combined oral contraceptives E Ezcurra
March 12 09.00 Preventing unsafe abortion R Kulier      
10.00 Future methods of fertility regulation C d'Arcangues
11.00 Emergency contraception H von Hertzen
March 15 09.00 Female sterilization HB Peterson      
10.00 Medical eligibility criteria for contraceptives HB Peterson
March 16 09.00 Investigation of the infertile couple A Campana      
10.00 Treatment of infertility A Campana
11.00 Treatment of infertility A Campana
12.00 Surgical treatment of male infertility G de Boccard
March 17 09.00 Osteoporosis R Rizzoli      
10.00 Assisted reproductive technologies H Lucas
11.00 Ethical issues in assisted reproductive technologies E Vayena
12.00 Menstrual cycle disorders D Chardonnens
March 18 09.00 Recurrent miscarriage A Campana 14.00 Laparoscopy in developing countries P Meyer
10.00 Menopause G Bianchi
11.00 Hormone replacement therapy G Bianchi
March 19 09.00 Designing and evaluating clinical algorithms for STI case management F Ndowa /
S Dludlu		      
10.00 HIV infection in pregnancy F Ndowa
11.00 STIs and bacterial vaginosis in pregnancy F Ndowa /
F Hawkes
March 22 09.00 Dual protection: prevention of STIs/HIV and pregnancy K O'Reilly      
11.00 Cervical cancer: screening and detection P Vassilakos
12.00 Colposcopy E Mégevand
March 23 09.00 HPV infection in gynaecology: prophylactic and therapeutic vaccines P-Y Dietrich      
11.00 Breast Cancer: diagnosis and treatment G Vlastos
12.00 Palliative care N Steiner
March 24 08.30 Introduction to the obstetrics module J Villar      
09.00 Prenatal diagnosis Ph Extermann
10.00 Ultrasound in obstetrics Ph Extermann
11.00 Evidence Based Antenatal Care J Villar
12.00 Impaired fetal growth M Merialdi
March 25 09.00 Treatment of hypertension in pregnancy L Say 14.00 Making pregnancy safer R Kabra
10.00 Nutritional interventions during pregnancy for the prevention of maternal morbidity, mortality and preterm delivery M Merialdi
11.00 Cesarean section in the world - A critical appraisal JG Cecatti
12.00 Obstetric anaesthesia and analgesia M Cherian
March 26 09.00 Neonatal resuscitation D Woods      
10.00 Prevention and treatment of postpartum haemorrhage M Gülmezoglu
11.00 Postpartum infection N Nik
12.00 Obstetrical vaginal fistula: surgical approach C-H Rochat
March 29, 30, April 01   Exams        

Course 2 : Chronic Disease at WHO/room M605

 Date AM Topic Speaker PM Topic Speaker
March 08 09.30 A Global Approach: Addressing the leading causes of death and disability C Le Galès-Camus      
10.15 Responding to the burden of NCDs R Beaglehole
11.15 Developing research protocols and proposals: open session for students C Tukuitonga / A Kalache
March 09 09.00 Global burden of disease-data, methods, results overview C Mathers      
10.15 Comparative risk assessment for NCDs K Strong /
C Mathers
11.15 Epidemiological approaches to measurement of risk K Sibuya
March 10 09.00 Surveillance - Introduction and STEPS R Bonita /
T Armstrong		      
10.15 Surveillance - InfoBase R Bonita /
K Strong
11.15 Surveillance-Global Youth Health Surveys L Riley      
March 11 09.00 Data sources / Existing data sources for NCDs K Strong      
10.15 Global strategy on diet, physical activity and health A Waxman
11.15 Schools setting for NCD prevention? C Gollmar
March 12 09.00 Primary Prevention of NCDs C Tukuitonga      
10.15 Managing behavioral risks J Epping-Jordan
11.15 Primary prevention: physical activity T Armstrong
March 15 09.00 Mental Health & substance abuse J Bertolote      
10.15 Mental Health & substance abuse J Bertolote
11.15 Mental Health & substance abuse J Bertolote
March 16 09.00 Evidence-based approaches to the prevention of CVDs
Cost Effective Cardiovascular Interventions for low and middle income countries		 S Mendis      
10.15 CVD risk assessment & management with hypertension as the entry point
2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension		 S Mendis
11.15 Primary and secondary prevention of myocardial infarction, stroke and rheumatic heart disease
Prevention of Recurrent Heart Attacks and Strokes in Low and Middle Income Populations		 S Mendis
March 17 09.00 Secondary prevention: screening (breast cancer) A Ullrich      
10.15 Primary prevention: Tobacco C Audera
11.15 Primary prevention: FCTC W Onizivu / G Vestal
March 18 09.00 Stroke T Truelsen      
10.15 Stroke T Truelsen
11.15 Stroke T Truelsen
March 19 09.00 The global burden of diabetes N Unwin      
10.15 The prevention of diabetes and its complications N Unwin
11.15 Diabetes Action Now - A joint World Health Organization (WHO) - International Diabetes Federation (IDF) Programme N Unwin
March 22 09.00 Chronic diseases and risks: the long-term view C Hawkes      
10.15 Integrated NCD prevention R Shao
11.15 HP effectiveness KC Tang
March 23 09.00 NCCP working groups A Ullrich      
10.15 NCCP working groups A Ullrich
11.15 NCCP working groups A Ullrich
March 24 09.00 NCD risks: a lifecourse perspective A Kalache      
10.15 Ageing and NCDs A Kalache
11.15 Ageing and NCDs A Kalache
March 25 09.00 Primary prevention: Alcohol L Riley      
10.15 Alcohol and drugs I Obot
11.15 Primary prevention: Nutrition and diet C Nishida
March 26 09.00 Improving health care for chronic conditions J Epping-Jordan      
10.15 Improving health care for chronic conditions J Epping - Jordan
March 29 09.00 Violence and injuries D Meddings      
10.15 Violence and injuries D Meddings
11.15 Violence and injuries D Meddings
March 30 09.00 - 12.00 Exams C Tukuitonga      
March 31, April 01 09.00 - 12.00 Review All      
April 02 09.00 - 12.00 Presentations All      

 
Web www.gfmer.ch

print
Print this page

line

Edited by Aldo Campana,